Amedisys Signs Definitive Agreement to Acquire Compassionate Care Hospice

Go back to Amedisys Signs Definitive Agreement to Acquire Compassionate Care Hospice

Amedisys (AMED) PT Raised to $125 at Cantor Fitzgerald

October 11, 2018 9:10 AM EDT

Cantor Fitzgerald analyst Joseph France raised the price target on Amedisys (NASDAQ: AMED) to $125.00 (from $117.00) while maintaining a Neutral rating. Cantor Fitzgerald increased 2019 estimates to reflect the accretive impact of the Compassionate Care acquisition on AMED's earnings.

Cantor Fitzgerald raised 2019 revenue estimate to $1.93 billion (from $1.75... More